Taraxacum mongolicum extract induced endoplasmic reticulum stress associated-apoptosis in triple-negative breast

Xiao-Hong Li1, Xi-Ran He1, Yan-Yan Zhou2

  • 1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Chinese and Western Medicine, Peking University Cancer Hospital and Institute, Beijing 100142, PR China.

Abstract

Insights

Dandelion extract shows anti-cancer effects against triple-negative breast cancer (TNBC) by inducing cell death through endoplasmic reticulum (ER) stress. This natural compound may offer a new therapeutic strategy for TNBC treatment.

Area of Science:

  • Phytochemistry
  • Molecular Biology
  • Oncology

Background:

  • Triple-negative breast cancer (TNBC) is an aggressive subtype with limited therapeutic options.
  • Taraxacum mongolicum (dandelion) possesses known anti-cancer properties, but its mechanisms in TNBC require elucidation.
  • Traditional use of dandelion for mammary conditions suggests potential efficacy.

Purpose of the Study:

  • To investigate the therapeutic effects of dandelion extract on TNBC cells.
  • To elucidate the molecular mechanisms underlying dandelion's anti-cancer activity in TNBC.
  • To assess the role of endoplasmic reticulum (ER) stress in dandelion-induced apoptosis.

Main Methods:

  • Preparation and chemical characterization of dandelion extract.
  • Assessment of cell viability (MTT assay), cell cycle, and apoptosis (flow cytometry) in TNBC cells.
  • Analysis of gene and protein expression (RT-PCR, Western blotting) and manipulation of ER stress pathways (caspase inhibitor, CHOP siRNA).

Main Results:

  • Dandelion extract reduced MDA-MB-231 cell viability and induced G2/M phase arrest and apoptosis.
  • Dandelion treatment increased cleaved caspase-3 and PARP, indicating apoptosis activation.
  • ER stress pathways (PERK/eIF2α/ATF4/CHOP axis) were significantly activated, mediating apoptosis.

Conclusions:

  • Dandelion extract exhibits anti-cancer effects in TNBC cells primarily through ER stress-induced apoptosis.
  • The findings support dandelion extract as a potential complementary therapeutic agent for TNBC.
  • Further research into dandelion's mechanisms could lead to novel TNBC treatment strategies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K